Mutz Christopher

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 53% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mutz Christopher's trades of ANI Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
60.45
Quantity 4,000 -3.6%
Value US$241,800
Transaction date
Sale
Price
57.70
Quantity 6,500 -7.8%
Value US$375,050
Transaction date
Sale
Price
61.61
Quantity 2,000 -2.3%
Value US$123,220
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-13
PlS Planned sale
91,217 -1.5%
141.46
US$4,840,366 		91,217 -1.5% 141.46 US$4,840,366
2026-03-10 2026-03-09
PlS Planned sale
40,095 +23.1%
133.01
US$1,436,214 		40,095 +23.1% 133.01 US$1,436,214
2026-03-10 2026-03-06
PlS Planned sale
21,625 +43.0%
313.96
US$4,005,104 		21,625 +43.0% 313.96 US$4,005,104
2026-03-04 2026-03-02
PlS Planned sale
417 -0.4%
74.00
US$30,858 		417 -0.4% 74.00 US$30,858
2026-02-23 2026-02-20
PlS Planned sale
5,323 -5.9%
78.02
US$415,300 		5,323 -5.9% 78.02 US$415,300
2026-02-17 2026-02-12
PlS Planned sale
7,032 -7.1%
76.55
US$538,300 		7,032 -7.1% 76.55 US$538,300
2025-05-15 2025-05-14
S Sale
4,000 -3.6%
60.45
US$241,800 		4,000 -3.6% 60.45 US$241,800
2024-11-18 2024-11-15
S Sale
6,500 -7.8%
57.70
US$375,050 		6,500 -7.8% 57.70 US$375,050
2024-05-22 2024-05-21
S Sale
2,000 -2.3%
61.61
US$123,220 		2,000 -2.3% 61.61 US$123,220
2024-03-06 2024-03-05
S Sale
5,000 -5.4%
66.00
US$330,000 		5,000 -5.4% 66.00 US$330,000
2023-11-13 2023-11-10
S Sale
3,000 -4.5%
52.47
US$157,410 		3,000 -4.5% 52.47 US$157,410